- Home
- SONN vs HSCS Comparison
SONN vs HSCS Comparison
Compare SONN & HSCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SONN
- HSCS
- Stock Information
- Founded
- SONN N/A
- HSCS 2007
- Country
- SONN United States
- HSCS United States
- Employees
- SONN N/A
- HSCS N/A
- Industry
- SONN Biotechnology: Pharmaceutical Preparations
- HSCS Medical Specialities
- Sector
- SONN Health Care
- HSCS Health Care
- Exchange
- SONN Nasdaq
- HSCS Nasdaq
- Market Cap
- SONN 3.8M
- HSCS 3.7M
- IPO Year
- SONN N/A
- HSCS 2022
- Fundamental
- Price
- SONN $3.54
- HSCS $3.38
- Analyst Decision
- SONN Strong Buy
- HSCS Strong Buy
- Analyst Count
- SONN 1
- HSCS 2
- Target Price
- SONN $20.00
- HSCS $13.00
- AVG Volume (30 Days)
- SONN 934.4K
- HSCS 139.1K
- Earning Date
- SONN 08-26-2025
- HSCS 09-11-2025
- Dividend Yield
- SONN N/A
- HSCS N/A
- EPS Growth
- SONN N/A
- HSCS N/A
- EPS
- SONN N/A
- HSCS N/A
- Revenue
- SONN $1,000,000.00
- HSCS $4,350.00
- Revenue This Year
- SONN $5,376.22
- HSCS $21,003.45
- Revenue Next Year
- SONN N/A
- HSCS $533.33
- P/E Ratio
- SONN N/A
- HSCS N/A
- Revenue Growth
- SONN 978.39
- HSCS N/A
- 52 Week Low
- SONN $1.08
- HSCS $2.36
- 52 Week High
- SONN $19.30
- HSCS $6.47
- Technical
- Relative Strength Index (RSI)
- SONN 48.94
- HSCS 44.73
- Support Level
- SONN $2.80
- HSCS $3.33
- Resistance Level
- SONN $4.29
- HSCS $3.82
- Average True Range (ATR)
- SONN 0.55
- HSCS 0.32
- MACD
- SONN -0.02
- HSCS 0.00
- Stochastic Oscillator
- SONN 58.56
- HSCS 52.69
About SONN Sonnet BioTherapeutics Holdings Inc.
Sonnet BioTherapeutics Holdings Inc is a clinical-stage biotechnology company. The Company views its operations and manages its business in one segment. The company has developed FHAB (Fully Human Albumin Binding) technology which is well suited for drug development across a range of human disease areas, including in oncology, autoimmune, pathogenic, inflammatory, and hematological conditions. The firm's pipeline products include SON-080 (low-dose IL-6), SON-1210 (IL15- FHAB-IL12), SON-1010 (IL12-FHAB), and others.
About HSCS Heart Test Laboratories Inc.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.